Source:
reutersWASHINGTON (Reuters) – The United States said on Monday it had cut in half its order for H1N1 flu vaccine from Australia's CSL Ltd, but said it is not certain how far orders from other suppliers will be trimmed.
While U.S. officials are still calculating how much swine flu vaccine they will need, it is becoming increasingly clear that the United States will not need all 251 million doses it ordered from five companies.
...
The United States has received 136 million doses of H1N1 vaccine from its five suppliers -- CSL, Glaxo, Sanofi, AstraZeneca unit MedImmune and Novartis, and the U.S. Centers for Disease Control and Prevention says more than 60 million people have been vaccinated.
While the pandemic is slowing down in North America, the World Health Organization said on Monday the virus was still active in parts of central, eastern and southeastern Europe, North Africa and South Asia.
Read more:
http://news.yahoo.com/s/nm/20100111/ts_nm/us_flu_vaccines
france was selling its own reserve, a news from some days ago.